Abionyx: cash position of 1.9 million euros at the end of June
By way of comparison, the biotech company had cash and cash equivalents of nearly 2.9 million euros as of March 31 and four million euros as of December 31, 2022.
After elimination of intra-group transactions, the company recorded consolidated half-year sales of 2.1 million euros.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction